Diffusion Pharmaceuticals » Presentations http://www.diffusionpharma.com Mon, 06 Feb 2012 14:39:17 +0000 en hourly 1 http://wordpress.org/?v=3.1 Diffusion Pharmaceuticals Achieves Positive Results in Phase I/II Clinical Trial of Trans Sodium Crocetinate in Peripheral Artery Disease; Drug Offers Promise for Range of Serious Hypoxia-Related Medical Conditions http://www.diffusionpharma.com/research/diffusion-pharmaceuticals-achieves-positive-results-in-phase-iii-clinical-trial-of-trans-sodium-crocetinate-in-peripheral-artery-disease-drug-offers-promise-for-range-of-serious-hypoxia-related-medi http://www.diffusionpharma.com/research/diffusion-pharmaceuticals-achieves-positive-results-in-phase-iii-clinical-trial-of-trans-sodium-crocetinate-in-peripheral-artery-disease-drug-offers-promise-for-range-of-serious-hypoxia-related-medi#comments Mon, 15 Nov 2010 20:30:37 +0000 Tracey Danner http://www.diffusionpharma.com/?p=358 http://www.diffusionpharma.com/research/diffusion-pharmaceuticals-achieves-positive-results-in-phase-iii-clinical-trial-of-trans-sodium-crocetinate-in-peripheral-artery-disease-drug-offers-promise-for-range-of-serious-hypoxia-related-medi/feed 0 Results of Phase I/II Clinical Trial of TSC in Patients with Peripheral Artery Disease (PAD) to be Presented at American Heart Association Scientific Sessions November 15, 2010 http://www.diffusionpharma.com/uncategorized/results-of-phase-iii-clinical-trial-of-tsc-in-patients-with-peripheral-artery-disease-pad-to-be-presented-at-american-heart-association-scientific-sessions-november-15-2010 http://www.diffusionpharma.com/uncategorized/results-of-phase-iii-clinical-trial-of-tsc-in-patients-with-peripheral-artery-disease-pad-to-be-presented-at-american-heart-association-scientific-sessions-november-15-2010#comments Tue, 09 Nov 2010 20:40:34 +0000 Tracey Danner http://www.diffusionpharma.com/?p=348 http://www.diffusionpharma.com/uncategorized/results-of-phase-iii-clinical-trial-of-tsc-in-patients-with-peripheral-artery-disease-pad-to-be-presented-at-american-heart-association-scientific-sessions-november-15-2010/feed 0 Diffusion Pharmaceuticals LLC Announces Publication of Three Studies Testing Trans Sodium Crocetinate (TSC); Statistically significant results seen in animal models of primary brain cancer, cerebral ischemia and stroke http://www.diffusionpharma.com/uncategorized/diffusion-pharmaceuticals-llc-announces-publication-of-three-studies-testing-trans-sodium-crocetinate-tsc-statistically-significant-results-seen-in-animal-models-of-primary-brain-cancer-cerebral-i http://www.diffusionpharma.com/uncategorized/diffusion-pharmaceuticals-llc-announces-publication-of-three-studies-testing-trans-sodium-crocetinate-tsc-statistically-significant-results-seen-in-animal-models-of-primary-brain-cancer-cerebral-i#comments Tue, 23 Feb 2010 19:44:09 +0000 Tracey Danner http://www.diffusionpharma.com/?p=174 http://www.diffusionpharma.com/uncategorized/diffusion-pharmaceuticals-llc-announces-publication-of-three-studies-testing-trans-sodium-crocetinate-tsc-statistically-significant-results-seen-in-animal-models-of-primary-brain-cancer-cerebral-i/feed 0